- Home
- A-Z Publications
- Current Topics in Medicinal Chemistry
- Previous Issues
- Volume 21, Issue 24, 2021
Current Topics in Medicinal Chemistry - Volume 21, Issue 24, 2021
Volume 21, Issue 24, 2021
-
-
Prodrug Strategies for Critical Drug Developability Issues: Part I
By Xingyue JiDrug development is a very time, capital, and labor-intensive process. It was anticipated that bringing a novel chemical entity to market would take over a billion dollars and around 14 years [1]. In addition, drug development is characterized by a very high attrition rate both in preclinical and clinical studies. It was reported that only 40% of drug candidates with the most drug-like properties could make their way into clinical tri Read More
-
-
-
Prodrug Strategies in the CNS Drugs: Small Modification Makes Big Improvements
Authors: Ting Kang, Zhuang Miao, Siyu Liu and Bowen KeProdrug design is an effective method proven to improve the drug-like properties of a molecule, and it has been widely used in the drug development of various diseases. Due to the complexity of the central nervous system (CNS), the development of CNS drugs has high requirements related to the pharmaceutical, pharmacokinetic, and pharmacodynamic properties of the molecules. Prodrug design has now been wide Read More
-
-
-
Amino Acid Derived Prodrugs: An Approach to Improve the Bioavailability of Clinically Approved Drugs
Authors: Yogesh Singh, Samriti Saklani, Tanmoy Tantra and Suresh TharejaAmino acids derived prodrugs emerged as an attractive approach to improve oral delivery of drugs with low solubility and permeability. Conjugation of amino acids with parent drug molecules resulted in several-fold increases in water solubility. Acceptability of the amino acids derived prodrug approach increases day by day to fulfill the different characteristics needed to get the desired pharmacological or therapeutic activity. D Read More
-
-
-
The Application of Prodrug-based Drug Delivery Strategy in Anticancer Drugs
Authors: Nanxin Liu, Qinhua Chen, Qingqing Zhang, Jin Wang, Ru Si, Jie Zhang and Xiaoyan PanCancer is the second leading cause of human death after cardiovascular disease, and the most used drugs in clinics are cytotoxic agents. However, these drugs have some inherent disadvantages, such as the risk of toxicity, low selectivity, poor solubility, and so on. To overcome these shortcomings, a variety of drug delivery strategies based on prodrugs have been developed. The application of drug delivery systems ca Read More
-
-
-
Transition Metal-mediated Uncaging Chemistry in Prodrug Design
Authors: Hai Y. Shu, Ren De Zhu, Jing Wu, Xin Hua Liu and Jing Bo ShiUncaging chemistry catalyzed by transition metals is developed from deprotection reactions and metal-organic catalytic reactions. Also, it has the characteristics of high efficiency, simplicity and rapidity in the living biological system. In the past decade, metal encapsulation systems (such as nanoparticles) and metal complexes have been developed to reveal the reactivity of transition metals (including palladium, ruthenium, a Read More
-
-
-
The Insights and Perspectives of Nitric Oxide-mediated Biofilm Eradication
Authors: Mingke Yuan, Tao Sun, Jianbing Wu, Yue Fei, Yueqi Yang, Yong Ling, Yihua Zhang and Zhangjian HuangBiofilms are among the most important causes of nosocomial and recurrent infections as biofilms confer antibiotic resistance to pathogenic bacteria and protect them from the host’s immune system. Thus, it is imperative to investigate effective therapeutic agents to counteract biofilms. As an important signaling molecule, Nitric Oxide (NO) plays a crucial role in various biological and pathological processes. NO could disp Read More
-
-
-
Recent Development of Hydrogen Sulfide Therapeutics in the Treatment of Cardiovascular Diseases
Authors: Wen Peng, Weiwei Guo and Yueqing ZhengHydrogen sulfide (H2S), as one of the endogenous gasotransmitters, has shown great potential in treating cardiovascular diseases (CVDs). H2S plays a protective role in CVDs by removing reactive oxygen species (ROS), promoting vasodilation, inhibiting myocardial hypertrophy, preventing thrombosis, and protecting mitochondria. However, there still exist some problems for H2S as drugs such as challenging delivery, uncon Read More
-
Volumes & issues
-
Volume 25 (2025)
-
Volume 24 (2024)
-
Volume 23 (2023)
-
Volume 22 (2022)
-
Volume 21 (2021)
-
Volume 20 (2020)
-
Volume 19 (2019)
-
Volume 18 (2018)
-
Volume 17 (2017)
-
Volume 16 (2016)
-
Volume 15 (2015)
-
Volume 14 (2014)
-
Volume 13 (2013)
-
Volume 12 (2012)
-
Volume 11 (2011)
-
Volume 10 (2010)
-
Volume 9 (2009)
-
Volume 8 (2008)
-
Volume 7 (2007)
-
Volume 6 (2006)
-
Volume 5 (2005)
-
Volume 4 (2004)
-
Volume 3 (2003)
-
Volume 2 (2002)
-
Volume 1 (2001)
Most Read This Month
Article
content/journals/ctmc
Journal
10
5
false
en
